London
· Delayed Price · Currency is GBP · Price in EUR DSM-Firmenich AG Company Description
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments.
The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients. The Taste, Texture & Health segment provides food and beverages solutions, including flavors, natural extracts, and sugar reduction; and food enzymes, cultures, hydrocolloids, proteins, natural colorants, nutritional ingredients, premixes and yeast extracts solutions.
The Animal Nutrition & Health segment offers animal proteins, as well as vitamins, performance solutions, and data-driven precision services for the animal production industry.
The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, biomedical materials, and nutrition improvement markets.
This segment offers vitamins, nutritional lipids, minerals, carotenoids, botanical nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise services, and customized solutions.
The company was founded in 1902 and is based in Kaiseraugst, Switzerland.
| Country | Switzerland |
| Founded | 1902 |
| Industry | Chemicals and Allied Products |
| Employees | 28,685 |
| CEO | Dimitri de Vreeze |
Contact Details
Address: Wurmisweg 576 Kaiseraugst, 4303 Switzerland | |
| Phone | 41 61 815 17 26 |
| Website | dsm-firmenich.com |
Stock Details
| Ticker Symbol | 0AC9 |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2800 |
Key Executives
| Name | Position |
|---|---|
| Dimitri de Vreeze | Chief Executive Officer |
| Ralf Schmeitz | Chief Financial Officer |
| Dave Huizing | Head of Investor Relations |